XML 56 R40.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF PURCHASE CONSIDERATIONS (Details) - USD ($)
1 Months Ended 12 Months Ended
Apr. 04, 2022
Jul. 31, 2022
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]      
Total purchase consideration     $ 6,000,000.0
Precision Healing Inc [Member]      
Restructuring Cost and Reserve [Line Items]      
Cash paid to non-accredited investors $ 125,370    
Cash paid for fractional shares 596    
Carrying value of equity method investment in Precision Healing 1,803,440    
Fair value of contingent earnout consideration 3,882,151    
Direct transaction costs 1,061,137    
Total purchase consideration $ 16,581,783    
Precision Healing Inc [Member] | Equity Option [Member]      
Restructuring Cost and Reserve [Line Items]      
Equity Shares 144,191    
Fair value of stok issued, value $ 4,109,750    
Precision Healing Inc [Member] | Common Stock [Member]      
Restructuring Cost and Reserve [Line Items]      
Equity Shares 165,738    
Fair value of stok issued, value $ 5,096,444    
Precision Healing Inc [Member] | Warrant [Member]      
Restructuring Cost and Reserve [Line Items]      
Equity Shares 16,725    
Fair value of stok issued, value $ 502,895    
Scendia Purchase Agreement [Member] | Common Stock [Member]      
Restructuring Cost and Reserve [Line Items]      
Equity Shares   291,686  
Fair value of stok issued, value   $ 6,032,066  
Fair value of contingent earnout consideration   3,000,000  
Total purchase consideration   10,594,734  
Cash consideration   $ 1,562,668